ARMR Sciences Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

ARMR Sciences General Information

Description

Developer of biodefense therapeutics designed to provide preventive protection against synthetic drug threats. The company develops immunotherapy-based countermeasures targeting fentanyl and other chemical and biological threats using immune system activation technology, enabling military personnel, first responders, and individuals to reduce the risk of overdose and exposure to emerging synthetic drugs.

Contact Information

Formerly Known As
Ovax
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12 East 49th Street
  • New York, NY 10017
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Aerospace and Defense
Pharmaceuticals
Vertical(s)
Corporate Office
  • 12 East 49th Street
  • New York, NY 10017
  • United States
+1 (212)

ARMR Sciences Timeline

202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ARMR Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 23-Jun-2026 Completed Pre-Clinical Trials
2. Early Stage VC 26-Jun-2024 Completed Pre-Clinical Trials
1. Seed Round 01-Jan-2023 Completed Startup
To view ARMR Sciences’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ARMR Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ARMR Sciences Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Mad Advising Venture Capital Minority
Angel (individual) Minority
Mach5 Capital Family Office Minority
Manta Capital Advisors Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 8 investors. Get the full list »

ARMR Sciences FAQs

  • When was ARMR Sciences founded?

    ARMR Sciences was founded in 2023.

  • Where is ARMR Sciences headquartered?

    ARMR Sciences is headquartered in New York, NY.

  • What is the size of ARMR Sciences?

    ARMR Sciences has 6 total employees.

  • What industry is ARMR Sciences in?

    ARMR Sciences’s primary industry is Drug Discovery.

  • Is ARMR Sciences a private or public company?

    ARMR Sciences is a Private company.

  • What is ARMR Sciences’s current revenue?

    The current revenue for ARMR Sciences is .

  • How much funding has ARMR Sciences raised over time?

    ARMR Sciences has raised $10M.

  • Who are ARMR Sciences’s investors?

    Mad Advising, , Mach5 Capital, Manta Capital Advisors, and are 5 of 8 investors who have invested in ARMR Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process